Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Share-based Compensation (2016 - 2025)

InspireMD's Share-based Compensation history spans 16 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 21.4% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $7.3 million, up 10.85%, while the annual FY2025 figure was $12.3 million, 21.64% up from the prior year.
  • Share-based Compensation reached $2.8 million in Q4 2025 per NSPR's latest filing, up from $567000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.8 million in Q4 2025 to a low of $289000.0 in Q1 2023.
  • Average Share-based Compensation over 5 years is $1.1 million, with a median of $678000.0 recorded in 2022.
  • Peak YoY movement for Share-based Compensation: crashed 55.74% in 2023, then surged 805.88% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $566000.0 in 2021, then crashed by 34.98% to $368000.0 in 2022, then surged by 348.1% to $1.6 million in 2023, then surged by 42.27% to $2.3 million in 2024, then increased by 21.4% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Share-based Compensation are $2.8 million (Q4 2025), $567000.0 (Q3 2025), and $1.1 million (Q2 2025).